Blood Cancer Research Moves from Lab to Clinic with UR CTSI Help

Laura Calvi, M.D., a co-leader of Wilmot Cancer Institute’s Cancer Microenvironment research program, recently achieved what a lot of researchers only dream of: her years of lab research have translated to a clinical trial that has begun to benefit patients. With the help of a UR CTSI Incubator award, Calvi’s discoveries from the lab are starting to have a tangible impact on patients with myelodysplastic syndrome, a type of blood cancer that requires frequent blood transfusions.

Like many successful translational projects, Calvi cites a strong team approach and many close collaborations as the keys to the project’s success.  

Learn how the drugs being tested in Calvi’s clinical trial have reduced one Penfield patient’s need for a blood transfusions. 

Michael Hazard | 2/5/2021

You may also like